Table 1.
Characteristics of patients
Cohort 1 (n = 20)* | Cohort 2 (n = 64)* | Cohort 3 (n = 33)* | |
Sex | 14 male, 6 female | 44 male, 20 female | 19 male, 14 female |
Age in years† | 3.5 (0.4-12.6) | 2.1 (0.35-15.6) | 1.7 (0.1-4.5) |
Coronary artery status‡ | 11 N, 7 D, 2 A | 33 N, 22 D, 9 A | 26 N, 3 D, 4 A |
IVIG response§ | 14 R, 4 NR | 45 R, 8 NR | 22 R, 11 NR |
Illness day, acute sample† | Day 6 (4-12) | Day 6 (2-14) | Day 5 (3-7) |
Illness day, subacute sample† | Day 20 (12-24)¶ | NA | NA |
Illness day, convalescent sample† | Day 47 (32-64)¶ | NA | NA |
*Seven individuals were in both cohort 1 and cohort 2; three additional individuals were in both cohort 1 and cohort 3. †Data presented as median (range). ‡Arterial diameter determined by echocardiogram. N, normal; D, dilated; A; aneurysm. §R, IVIG responder; NR, IVIG non-responder. Two patients in cohort 1 and 11 in cohort 2 were treated with IVIG after illness day 10 and excluded from analysis of IVIG response. ¶Additional samples were obtained from three patients less than 48 h after treatment with IVIG on illness days 7, 8, and 13; one additional sample was obtained from a fourth patient at a 1-year follow-up. NA, not applicable.